Results 221 to 230 of about 43,499 (244)
Some of the next articles are maybe not open access.
Poly (ADP-ribose) polymerase inhibitor efficacy in head and neck cancer
Oral Oncology, 2014Poly (ADP-ribose) polymerase inhibitors (PARPi) have shown single agent activity against tumors with deficiencies in the DNA repair mechanism homologous recombination including, but not limited to those harboring BRCA mutations. We hypothesized that, in the context of homologous recombination deficiency (HRD), PARPi could have an effect in head and ...
Jana Heitmann +6 more
openaire +2 more sources
Poly(ADP-ribose) polymerase (PARP) and PARP inhibitors
Drug Discovery Today: Disease Models, 2012PARP-1 protects cells from endogenous and therapeutically inflicted DNA damage. PARP inhibitors have been under development since 1980 and first entered clinical trial in 2003. They are an exciting new class of drugs that have the potential to increase the efficacy of anticancer DNA damaging agents and to selectively target cells that have defects in ...
openaire +2 more sources
A Review on Poly (ADP-ribose) Polymerase (PARP) Inhibitors and Synthetic Methodologies
Current Medicinal Chemistry, 2021Ying Li, Chen-Fu Liu, Guo-Wu Rao
exaly
Targeting angiogenesis with poly(ADP-ribose) polymerase inhibitors
2007The process of angiogenesis is mediated by a wide range of factors, including pro-inflammatory cytokines. On the basis of the involvement of inflammation in tumor development and of the dual role of PARP inhibitor as enhancer of chemotherapy or as anti-inflammatory agent we have investigated the ability of PARP inhibitors to affect endothelial ...
MUZI, ALESSIA +9 more
openaire +1 more source
Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer
The Cochrane Library, 2022Neil A J Ryan, Jo Morrison
exaly
Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic
Ca-A Cancer Journal for Clinicians, 2011Timothy A Yap +2 more
exaly
PARP Inhibitors (Poly(ADP-Ribose) Polymerase Inhibitors)
2013Larry C. Daugherty +117 more
openaire +1 more source

